Pentylenetetrazol: Facilitation of classical discrimination conditioning in rabbits

Richard Elliott; Neil Schneiderman

doi:10.1007/BF00401543

Pentylenetetrazol: Facilitation of classical discrimination conditioning in rabbits

Richard Elliott, Neil Schneiderman

Psychology

Research output: Contribution to journal › Article

6 Scopus citations

Abstract

Subcutaneous injections of pentylenetetrazol (25 mg/kg) reliably increased the rate of nictitating membrane acquisition and enhanced a respiration rate discrimination between stimuli, while leaving rate of heart rate conditioning and discrimination formation unaffected. These effects were response and dosage dependent, with the greatest enhancement of performance occurring at dosages just under the convulsion threshold. The data suggest that pentylenetetrazol enhanced performance in the nictitating membrane response system by increasing the probability that Ss would move from an inactive to an active response state.

Original language	English (US)
Pages (from-to)	133-141
Number of pages	9
Journal	Psychopharmacologia
Volume	12
Issue number	2
DOIs	https://doi.org/10.1007/BF00401543
State	Published - Jan 1 1968

Fingerprint

ASJC Scopus subject areas

Pharmacology

Cite this

Elliott, R., & Schneiderman, N. (1968). Pentylenetetrazol: Facilitation of classical discrimination conditioning in rabbits. Psychopharmacologia, 12(2), 133-141. https://doi.org/10.1007/BF00401543

@article{594334c95050491da8149a51fdc24af3,

title = "Pentylenetetrazol: Facilitation of classical discrimination conditioning in rabbits",

abstract = "Subcutaneous injections of pentylenetetrazol (25 mg/kg) reliably increased the rate of nictitating membrane acquisition and enhanced a respiration rate discrimination between stimuli, while leaving rate of heart rate conditioning and discrimination formation unaffected. These effects were response and dosage dependent, with the greatest enhancement of performance occurring at dosages just under the convulsion threshold. The data suggest that pentylenetetrazol enhanced performance in the nictitating membrane response system by increasing the probability that Ss would move from an inactive to an active response state.",

author = "Richard Elliott and Neil Schneiderman",

year = "1968",

month = jan,

day = "1",

doi = "10.1007/BF00401543",

language = "English (US)",

volume = "12",

pages = "133--141",

journal = "Psychopharmacology",

issn = "0033-3158",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Pentylenetetrazol

T2 - Facilitation of classical discrimination conditioning in rabbits

AU - Elliott, Richard

AU - Schneiderman, Neil

PY - 1968/1/1

Y1 - 1968/1/1

N2 - Subcutaneous injections of pentylenetetrazol (25 mg/kg) reliably increased the rate of nictitating membrane acquisition and enhanced a respiration rate discrimination between stimuli, while leaving rate of heart rate conditioning and discrimination formation unaffected. These effects were response and dosage dependent, with the greatest enhancement of performance occurring at dosages just under the convulsion threshold. The data suggest that pentylenetetrazol enhanced performance in the nictitating membrane response system by increasing the probability that Ss would move from an inactive to an active response state.

AB - Subcutaneous injections of pentylenetetrazol (25 mg/kg) reliably increased the rate of nictitating membrane acquisition and enhanced a respiration rate discrimination between stimuli, while leaving rate of heart rate conditioning and discrimination formation unaffected. These effects were response and dosage dependent, with the greatest enhancement of performance occurring at dosages just under the convulsion threshold. The data suggest that pentylenetetrazol enhanced performance in the nictitating membrane response system by increasing the probability that Ss would move from an inactive to an active response state.

UR - http://www.scopus.com/inward/record.url?scp=0014243559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014243559&partnerID=8YFLogxK

U2 - 10.1007/BF00401543

DO - 10.1007/BF00401543

M3 - Article

C2 - 5657049

AN - SCOPUS:0014243559

VL - 12

SP - 133

EP - 141

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -

Access to Document

10.1007/BF00401543